Comparison of self-collected versus clinician collected cervicovaginal specimens for detection of high risk human papillomavirus among HIV infected women in Ethiopia | BMC Women’s Health
, 2022-09-01 04:00:13,
Organization PAH. Plan of action for cervical cancer prevention and control 2018–2030. Washington, D.C.: PAHO; 2018.
WHO. International agency of research on cancer. Cervix uteri, Globocan 2020, 2021. p. 1–2.
Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16(32):41–9. https://doi.org/10.1016/S0968-8080(08)32415-X.
WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem and its associated goals and targets for the period 2020–2030, vol. 2, no. 1. 2020.
Baldwin S, Santos C, Brown EM, Nuno T, Giuliano A, John Davis J, et al. Comparison of type-specific human papillomavirus data from self and clinician directed sampling. Gynecol Oncol. 2005;97:612–7.
Berner A, Hassel SB, Tebeu PM, Untiet S, Fosso GK, Navarria I, et al. Human papillomavirus self-sampling in Cameroon: women’s uncertainties over the reliability of the method are barriers to acceptance. J Low Genit Tract Dis. 2013;17(3):235–41.
Flores CEF, Gutierrez GG, Leon JMO, Rodriguez DC, Sørbye SW. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests. BMC Infect Dis. 2021;21(1):1–9.
To read the original article from bmcwomenshealth.biomedcentral.com, Click here